Abstract: This invention is a process to manufacture a probiotic food supplement that can protect the human body from the harmful effects of ionizing and non-ionizing electromagnetic radiations such as gamma and X rays, as well as radio waves.
Abstract: A sensor implanted in tissues and including a sensing layer is fabricated by mixing the signal transduction enzyme with non-reactive components including buffer salts and fillers, and spin coating the enzyme onto a substrate. The signal transduction enzyme is crosslinked by introducing the coated substrate in a vacuum chamber. In the chamber, a crosslinker evaporates and is deposited onto the enzyme, therefore crosslinking the enzyme.
Type:
Grant
Filed:
May 17, 2023
Date of Patent:
April 30, 2024
Assignee:
CALIFORNIA INSTITUTE OF TECHNOLOGY
Inventors:
Samson Chen, Axel Scherer, Dvin I. Adalian, Peter Petillo, Muhammad Musab Jilani, Xiomara L. Madero, Deepan Kishore Kumar
Abstract: Microbial compositions for application to plants, plant parts and plant seeds are provided for improvement of plant yield and/or other beneficial plant traits. Methods of making and applying microbial compositions or formulations to plants, plant parts or plant seeds or to growth media are further provided to increase or improve plant yield and/or other beneficial plant traits.
Type:
Grant
Filed:
February 14, 2022
Date of Patent:
April 23, 2024
Assignee:
Monsanto Technology LLC
Inventors:
Kenneth L. Ferreira, Linda L. Lutfiyya, Ryan T. McCann, Scott R. Schaecher
Abstract: Materials and methods for conducting an atom transfer radical polymerization in the presence of oxygen by interlocking enzymatic activities are provided herein.
Type:
Grant
Filed:
September 12, 2022
Date of Patent:
March 5, 2024
Assignee:
Carnegie Mellon University
Inventors:
Krzysztof Matyjaszewski, Alan Enciso Barros, Liye Fu, Alan J. Russell
Abstract: An engineered microorganism(s) with novel pathways for the conversion of short-chain hydrocarbons to fuels and chemicals (e.g. carboxylic acids, alcohols, hydrocarbons, and their alpha-, beta-, and omega-functionalized derivatives) is described. Key to this approach is the use of hydrocarbon activation enzymes able to overcome the high stability and low reactivity of hydrocarbon compounds through the cleavage of an inert C—H bond. Oxygen-dependent or oxygen-independent activation enzymes can be exploited for this purpose, which when combined with appropriate pathways for the conversion of activated hydrocarbons to key metabolic intermediates, enables the generation of product precursors that can subsequently be converted to desired compounds through established pathways. These novel engineered microorganism(s) provide a route for the production of fuels and chemicals from short chain hydrocarbons such as methane, ethane, propane, butane, and pentane.
Type:
Grant
Filed:
May 19, 2020
Date of Patent:
February 27, 2024
Inventors:
Ramon Gonzalez, James Clomburg, Alexander Chou
Abstract: Disclosed herein relates to biopharmaceuticals, and more particularly to a continuous flow method for preparing (R)-3-hydroxy-5-hexenoate. Carbonyl reductase and isopropanol dehydrogenase are co-immobilized onto an inert solid medium simultaneously to prepare a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, which is then filled into a microchannel reactor of the micro reaction system. A solution containing substrate 3-carbonyl-5-hexenoate is subsequently pumped into the microchannel reactor to perform an asymmetric carbonyl reduction reaction to obtain (R)-3-hydroxy-5-hexenoate.
Abstract: The invention relates to methods of evaluating the quality of a batch of an herbal composition, the method comprising subjecting a test batch of the herbal composition to one or more biological analysis methods and comparing the results derived from the test batch to the results of a known batch of herbal composition which has a known in vivo effect.
Abstract: Methods of making a spheroid are provided whereby a suspension is first produced including one or more biologically-relevant materials dispersed within a biocompatible medium. A droplet of the suspension is then bioprinted into a salt solution by bringing the droplet into contact with a surface of the salt solution in a controlled manner to reproducibly yield a spheroid containing a desired size and a desired amount of biologically-relevant materials.
Type:
Grant
Filed:
December 17, 2020
Date of Patent:
February 13, 2024
Assignee:
University of Louisville Research Foundation, Inc.
Inventors:
Stuart K. Williams, Jeremy S. Touroo, James B. Hoying
Abstract: A further high-sensitive method for detection, determination, and activity measurement of peroxidase with no special enhancer argent. The substance, for example, high-concentration ammonium sulfate, is dissolved in the reaction solution to give rise to the micro-hydrophobic property, for detection, determination, and activity measurement of peroxidase using luminol and hydrogen peroxide as substrates.
Abstract: Bacterial cultures are provided that comprise a modified Pseudomonas aeruginosa bacterium missing or deficient in two or more virulence factors. The two or more virulence factors can be selected from exotoxin A, hemolytic phospholipase C, phenazine-specific methyltransferase, alpha-1,3-rhamnosyltransferase, and 3-phosphoshikimate 1-carboxyvinyltransferase. Certain of the modified Pseudomonas aeruginosa bacteria are also missing or deficient in one or more alginate acetylation enzymes including the alginate Oacetyltransferases AlgI, AlgJ, AlgF, AlgX, and/or the C5-mannuronan epimerase AlgG. Methods of producing alginate are also provided along with compositions comprising alginate produced by the modified Pseudomonas aeruginosa bacteria.
Type:
Grant
Filed:
March 14, 2019
Date of Patent:
January 16, 2024
Assignee:
MARSHALL UNIVERSITY RESEARCH CORPORATION
Inventors:
Hongwei D. Yu, Meagan E. Valentine, Richard M. Niles, Thomas Ryan Withers, Brandon D. Kirby
Abstract: The invention relates, in general, to methods of processing Lignocellulosic biomass to fermentable sugars and to methods that rely on hydrothermal pretreatment. Xylose monomer yields comparable to those achieved using two-stage pretreatments can be achieved from soft Lignocellulosic biomass feedstocks by pretreasting to very low severity in a single-stage pressurized hydrothermal pretreatment, followed by enzymatic hydrolysis to release xylose retained in the solid state. In some embodiments, pretreated biomass is separated into a solid fraction and a liquid fraction, the solid fraction subjected to enzymatic hydrolysis, and the separated liquid fraction subsequently mixed with the hydrolysed solid fraction.
Type:
Grant
Filed:
May 25, 2021
Date of Patent:
January 9, 2024
Assignee:
Inbicon A/S
Inventors:
Jan Larsen, Niels Nielsen Poulsen, Martin Dan Jeppesen, Kit Kellebjerg Mogensen
Abstract: The present invention provides a method and apparatus for tissue, such as an allograft, storage and preservation for extended periods of time at room temperature in a sterile tissue culture chamber. The invention further provides a process for maintaining the sterility of tissue using the apparatus as described.
Type:
Grant
Filed:
October 17, 2022
Date of Patent:
January 9, 2024
Assignees:
The Curators of the University of Missouri, The Trustees of Columbia University in New York
Inventors:
James L. Cook, Clark T. Hung, Eric Lima, Aaron Stoker
Abstract: A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
Type:
Grant
Filed:
January 17, 2023
Date of Patent:
January 2, 2024
Assignee:
EMULATE, INC.
Inventors:
Daniel Levner, Christopher David Hinojosa, Norman Wen, Antonio Varone, Justin Nguyen, Lina Williamson, S. Jordan Kerns, Catherine Karalis, Geraldine Hamilton, Carol Lucchesi
Abstract: Commercially available Quinoa grain powder is subjected to proteolytic digestion using papain enzyme. Derived hydrolysate is ultrafiltered using two sequential ultrafiltration steps of 50 KDa and 5 KDa membranes to remove high and low molecular impurities respectively. Concentrated filtrate is 0.2 ? filter-sterilized and used as a component growth medium for fastidious microorganisms Neisseria meningitidis and Streptococcus pneumoniae. The product is tested for its ability to be used as meat free nitrogen and carbon source for the fastidious bacterial growth and found to be working well.
Abstract: The present invention provides methods for removing a significant amount of bacteria (e.g., gram-negative bacteria and gram-positive bacteria, including bacteria with no or low affinity for heparan sulfate) from whole blood, serum or plasma using an adsorption media. The method can be used in extracorporeal treatments involving high volumetric flow rates and high linear flow rates.
Abstract: The present disclosure relates to methods and compositions for isolating mitochondria from cells and tissues. The methods provided herein are suitable for use in plants, animals, and fungi.
Abstract: Applications in transfusion medicine requiring platelets, and hematopoietic stem-cell transplantations require either platelets or enhancement of in vivo platelet biogenesis. Gene therapy applications of hematopoietic stem and progenitor cells (HSPCs) require effective and specific modification of HSPCs by DNA, RNA or other biological molecules. Here we disclose methods for the generation, and modification of megakaryocytic microparticles (MkMPs), proplatelets, preplatelets, platelet-like particles and megakaryocyte extracellular vesicles, that can be used in the aforementioned transfusion and transplantation medicine applications and in gene therapy applications involving hematopoietic stem cells.
Abstract: Pandemic COVID 19 causes global crisis in human health and economy. The pathogen of COVID 19, like the Influenzas causing common flus, belongs to a common type of virus called Ribonucleic Acid (RNA) virus. RNA viruses are composed of three structural components: genomic RNA, envelop and nuclear proteins, and bilayer lipid membrane. Targeting COVID 19 and all RNA viruses, the present invention describes an effective disinfectant system, which applies the combination of RNases, proteases, and detergents, at a broad range of concentration, pH, and temperature in the utilization, to eliminate the RNA viruses from any contaminated surfaces, airways, and filters. The disinfectant system provides an effective, convenient, environment friendly, and safe solution, for commercial and customer use, to disinfect RNA virus pathogens in concern.